Uptake index of 123I-metaiodobenzylguanidine myocardial scintigraphy for diagnosing Lewy body disease
Objective(s): Iodine-123 metaiodobenzylguanidine (123I-MIBG) myocardial scintigraphy has been used to evaluate cardiac sympathetic denervation in Lewy body disease (LBD), including Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). The heart-tomediastinum ratio (H/M) in PD and DLB is sign...
Main Authors: | Yoshito Kamiya, Satoru Ota, Shintaro Okumiya, Kosuke Yamashita, Akihiro Takaki, Shigeki Ito |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2017-01-01
|
Series: | Asia Oceania Journal of Nuclear Medicine and Biology |
Subjects: | |
Online Access: | http://aojnmb.mums.ac.ir/article_7972_c57c59db497957241928a594b8b80bdf.pdf |
Similar Items
-
Development of an 123I-metaiodobenzylguanidine Myocardial Three-Dimensional Quantification Method for the Diagnosis of Lewy Body Disease
by: Yoshito Kamiya, et al.
Published: (2018-06-01) -
Standardization of 123I-metaiodobenzylguanidine cardiac neurotropic scintigraphy and single-photon emission tomography
by: A. A. Ansheles, et al.
Published: (2016-07-01) -
I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature Review
by: Eun Joo Chung, et al.
Published: (2015-05-01) -
Dosimetry estimation of SPECT/CT for iodine 123-labeled metaiodobenzylguanidine in children
by: Aida Mhiri, et al.
Published: (2015-09-01) -
Incidental detection of synchronous medullary thyroid carcinoma with bilateral adrenal pheochromocytoma on iodine-123 metaiodobenzylguanidine scintigraphy, leading to diagnosis of multiple endocrine neoplasia 2A
by: Asif Ali Fakhri, et al.
Published: (2017-01-01)